PPARG and breast cancer: Retrospectively, we reveal a long-lasting positive effect on BC-specific outcome in patients treated with metformin (indirect signaling activator of PPAR-γ), and tumors from metformin-treated BC patients contained more LIPEC vessels than tumors from BC patients who did not receive this treatment.